Cart
sales@molnova.com
cyclo(L-Pro-L-Tyr)
CAS No. 4549-02-4
cyclo(L-Pro-L-Tyr)( —— )
Catalog No. M24409 CAS No. 4549-02-4
Maculosin is a secondary metabolite of fungi and bacteria.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 87 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 236 | In Stock |
|
| 50MG | 350 | In Stock |
|
| 100MG | 516 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namecyclo(L-Pro-L-Tyr)
-
NoteResearch use only, not for human use.
-
Brief DescriptionMaculosin is a secondary metabolite of fungi and bacteria.
-
DescriptionMaculosin is a secondary metabolite of fungi and bacteria.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4549-02-4
-
Formula Weight260.29
-
Molecular FormulaC14H16N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (384.19 mM)
-
SMILESOc1ccc(C[C@@H]2NC(=O)[C@@H]3CCCN3C2=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stierle A C , Cardellina J H , Strobel G A . Maculosin, a host-specific phytotoxin for spotted knapweed from Alternaria alternata[J]. Proceedings of the National Academy of Sciences, 1988, 85(21):8008-8011.
molnova catalog
related products
-
Pomalidomide-PEG3-CO...
Thalidomide-NH-PEG3-propionic acid is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-NH-PEG3-propionic acid incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.
-
Sincalide
Sincalide (INN) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin, and also known as CCK-8.
-
Tenilsetam
Tenilsetam is an endonuclease modulator; a nootropic agent and advanced glycation end product (AGE) inhibitor having potential for Alzheimer's disease (AD) treatment.
